Gainers
- Helius Medical Tech HSDT shares moved upwards by 32.6% to $0.92 during Wednesday's pre-market session. The company's market cap stands at $3.4 million.
- Climb Bio CLYM stock increased by 19.25% to $2.23. The market value of their outstanding shares is at $150.0 million.
- Exicure XCUR shares moved upwards by 15.42% to $9.95. The market value of their outstanding shares is at $30.2 million.
- Rapid Micro Biosystems RPID stock increased by 14.67% to $1.25. The company's market cap stands at $53.7 million.
- Generation Bio GBIO shares increased by 11.36% to $0.98. The company's market cap stands at $65.4 million.
- Context Therapeutics CNTX shares moved upwards by 11.09% to $1.1. The market value of their outstanding shares is at $82.4 million.
Losers
- Anitra AZTR stock fell 29.1% to $0.3 during Wednesday's pre-market session. The market value of their outstanding shares is at $2.2 million.
- GlucoTrack GCTK stock fell 23.2% to $0.09. The company's market cap stands at $1.5 million.
- Jin Medical International ZJYL shares fell 20.2% to $0.83. The market value of their outstanding shares is at $129.9 million.
- Theriva Biologics TOVX shares fell 15.19% to $1.62. The company's market cap stands at $4.5 million.
- Phio Pharma PHIO stock declined by 14.53% to $3.06. The company's market cap stands at $5.3 million.
- Ardent Health Partners ARDT stock declined by 14.52% to $12.01. The market value of their outstanding shares is at $1.7 billion. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
AZTRAzitra Inc
$0.2922-30.6%
CLYMClimb Bio Inc
$2.2721.4%
CNTXContext Therapeutics Inc
$1.0910.1%
GBIOGeneration Bio Co
$0.92054.60%
GCTKGlucoTrack Inc
$0.0881-27.8%
HSDTHelius Medical Technologies Inc
$0.962839.1%
PHIOPhio Pharmaceuticals Corp
$3.40-5.03%
RPIDRapid Micro Biosystems Inc
$1.2010.1%
TOVXTheriva Biologics Inc
$1.67-12.6%
XCURExicure Inc
$9.9515.4%
ZJYLJin Medical International Ltd
$0.8300-20.2%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in